OrbiMed Advisors LLC - Net Worth and Insider Trading

OrbiMed Advisors LLC Net Worth

The estimated net worth of OrbiMed Advisors LLC is at least $177,200 dollars as of 2024-11-13. OrbiMed Advisors LLC is the 10% Security Holder of HLS Therapeutics Inc and owns about 51,214 shares of HLS Therapeutics Inc (TSX:HLS) stock worth over $177,200. Details can be seen in OrbiMed Advisors LLC's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that OrbiMed Advisors LLC has not made any transactions after 2020-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of OrbiMed Advisors LLC

To

OrbiMed Advisors LLC Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, OrbiMed Advisors LLC owns 1 companies in total, including HLS Therapeutics Inc (TSX:HLS) .

Click here to see the complete history of OrbiMed Advisors LLC’s form 4 insider trades.

Insider Ownership Summary of OrbiMed Advisors LLC

Ticker Comapny Transaction Date Type of Owner
TSX:HLS HLS Therapeutics Inc 2020-03-03 10% Security Holder

OrbiMed Advisors LLC Latest Holdings Summary

OrbiMed Advisors LLC currently owns a total of 1 stock. OrbiMed Advisors LLC owns 51,214 shares of HLS Therapeutics Inc (TSX:HLS) as of March 3, 2020, with a value of $177,200.

Latest Holdings of OrbiMed Advisors LLC

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:HLS HLS Therapeutics Inc 2020-03-03 51,214 3.46 177,200

Holding Weightings of OrbiMed Advisors LLC


OrbiMed Advisors LLC Form 4 Trading Tracker

According to the SEC Form 4 filings, OrbiMed Advisors LLC has made a total of 14 transactions in HLS Therapeutics Inc (TSX:HLS) over the past 5 years, including 0 buys and 14 sells. The most-recent trade in HLS Therapeutics Inc is the sale of 11,890 shares on March 3, 2020, which brought OrbiMed Advisors LLC around $263,548.

Insider Trading History of OrbiMed Advisors LLC

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

OrbiMed Advisors LLC Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

OrbiMed Advisors LLC Ownership Network

Ownership Network List of OrbiMed Advisors LLC

No Data

Ownership Network Relation of OrbiMed Advisors LLC

Insider Network Chart

OrbiMed Advisors LLC Owned Company Details

What does HLS Therapeutics Inc do?

Who are the key executives at HLS Therapeutics Inc?

OrbiMed Advisors LLC is the 10% Security Holder of HLS Therapeutics Inc. Other key executives at HLS Therapeutics Inc include Director & Senior Officer Craig Millian , Senior Officer Brian Thomas Walsh , and 10% Security Holder Polar Asset Management Partners Inc. .

HLS Therapeutics Inc (TSX:HLS) Insider Trades Summary

Over the past 18 months, OrbiMed Advisors LLC made no insider transaction in HLS Therapeutics Inc (TSX:HLS). Other recent insider transactions involving HLS Therapeutics Inc (TSX:HLS) include a net purchase of 20,000 shares made by Tim Hendrickson , a net purchase of 12,500 shares made by Craig Millian , and a net purchase of 32,400 shares made by Polar Asset Management Partners Inc. .

In summary, during the past 3 months, insiders sold 0 shares of HLS Therapeutics Inc (TSX:HLS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,300,000 shares of HLS Therapeutics Inc (TSX:HLS) were sold and 167,100 shares were bought by its insiders, resulting in a net sale of 1,132,900 shares.

HLS Therapeutics Inc (TSX:HLS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

HLS Therapeutics Inc Insider Transactions

No Available Data

OrbiMed Advisors LLC Mailing Address

Above is the net worth, insider trading, and ownership report for OrbiMed Advisors LLC. Currently GuruFocus does not have mailing address information for OrbiMed Advisors LLC.